Title Collection Author Date
Why are Glaxo Shares Cheap? Equity Research & Insights James Gard 31/08/21
Should You Invest in the Vaccine Makers? Equity Research & Insights Rentsje de Gruyter 19/01/21
Stock of the Week: GlaxoSmithKline Equity Research & Insights Holly Black 20/08/20
Glaxo's Vaccines Division Outperforms Equity Research & Insights James Gard 24/07/19
Dividend Shares to Fund My Retirement Equity Research & Insights Emma Simon 10/07/19
3 Contrarian Stock Picks from Scottish Investment Trust Equity Research & Insights Holly Black 24/06/19
Merchants Trust Buys Back Into Tobacco Equity Research & Insights David Brenchley 07/03/19
GlaxoSmithKline Still Undervalued, say Analysts Equity Research & Insights Damien Conover 08/02/19
5 Worst-Performing FTSE 100 Stocks in 2018 Equity Research & Insights David Brenchley 28/12/18
5 Best FTSE 100 Stocks of 2018 Equity Research & Insights David Brenchley 27/12/18
GlaxoSmithKline Shares Still Undervalued Equity Research & Insights Damien Conover 31/07/18
Investor Views: “Why I’m Backing Higher Risk Funds” Investing for Retirement Emma Simon 14/06/18
Investor Views: “My Family Have Owned the Same Shares for 100 Years” Equity Research & Insights Emma Simon 23/05/18
Out-of-Favour UK Creating Investment Opportunities Fund Research & Insights David Brenchley 16/05/18
SIPP Investing: 10 Most-Bought Stocks Investing for Retirement David Brenchley 06/04/18
SIPP Investing: 10 Most-Sold Stocks Investing for Retirement David Brenchley 05/04/18
Can FTSE 100 Drug Giants Weather US Reforms? Equity Research & Insights Damien Conover 29/03/18
Best Performing FTSE 100 Stocks of 2017 Equity Research & Insights David Brenchley 19/12/17
Woodford on: Lloyds, Barclays, RBS, Astra and Glaxo Equity Research & Insights David Brenchley 10/11/17
Income Stock Picks of the Top Equity Fund Managers Fund Research & Insights David Brenchley 27/10/17
Glaxo Dividend Cut Unlikely say Analysts Equity Research & Insights Damien Conover 26/10/17
UK Pharma Stocks Fall as Trump Repeals Obamacare Equity Research & Insights Karen Kwok 02/02/17
Pharma Stocks Remain Undervalued Despite Clinton Loss Equity Research & Insights Karen Kwok 29/11/16
Which Stocks are UK Equity Income Fund Managers Buying? Equity Research & Insights Karen Kwok 11/08/16
Is Glaxo's Dividend at Risk? Equity Research & Insights Damien Conover, CFA 05/02/15
RBS Could Struggle to Find New Chairman Equity Research & Insights Holly Cook 26/09/14
Page   1 of 1
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement